Tardive dyskinesia: epidemiologic factors as a guide for prevention and management.
Casey
D E
DE
D000367:Age Factors; D000818:Animals; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001971:Bromocriptine / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004409:Dyskinesia, Drug-Induced / Q000175:diagnosis / Q000453:epidemiology* / Q000517:prevention & control; D000882:Haplorhini; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D010276:Parasympatholytics / Q000009:adverse effects; D012110:Reserpine / Q000627:therapeutic use; D012306:Risk
D014150:Antipsychotic Agents; D010276:Parasympatholytics; D001971:Bromocriptine; D007980:Levodopa; D012110:Reserpine